NxStage Medical (NXTM) Home Hemodialysis System Reduces Costs Over Time; Shows Increased Life Expectancy

August 9, 2013

NxStage Medical (NXTM) helps reduce overall health care costs by allowing patients to take the dialysis from the health care center to their home, increasing their quality and length of life while reducing their dependence on medications, says Chris Cooley, Managing Director at Stephens Inc.

“What NxStage does is they have a proprietary, and they are really one of only two that have what we call a home hemodialysis system. So patients can actually have a fuller, healthier life, have control of their day and do dialysis in the home setting as opposed to having a go in-center three days a week. It’s important in the sense these patients are healthier,” Cooley said.

FOR MORE INFORMATION ABOUT THIS INTERVIEW CLICK HERE.

Cooley says studies show patients using NXTM‘s technology live longer and use less medications, saving the health care system over time, combining better medicine with lower cost in the same solution — a service increasingly important given the disproportionate costs for treating the patient population that requires dialysis.

“This is a company which is focused on the dialysis marketplace, and it’s an important market in the sense that it’s only about 2% of the patients — I am sorry, 2% of the Medicare population — when we think about the patients in the U.S. each year. But they account for 8% of the annual Medicare outlay, so a disproportionate amount of costs associated with this patient population,” Cooley said.